(Q34565132)

English

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Burkitt lymphoma

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

16

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

object named as

Stefan Faderl

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Srdan Verstovsek

8

object named as

Srdan Verstovsek

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

William G Wierda

9

object named as

William G Wierda

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jorge Eduardo Cortes

5

object named as

Jorge Cortes

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

object named as

Susan O'Brien

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Guillermo Garcia-Manero

6

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michael J. Keating

14

object named as

Michael J Keating

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

12

object named as

Mark Brandt

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Carlos B Bueso-Ramos

4

object named as

Carlos Bueso-Ramos

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

11

object named as

Jianqin Shan

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Francis J Giles

7

object named as

Francis J Giles

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Fredrick B Hagemeister

13

object named as

Fredrick B Hagemeister

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Deborah A Thomas

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sherry A Pierce

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Fernando Cabanillas

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1569-1580

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Adult Burkitt leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

De novo acute B cell leukemia/lymphoma with t(14;18)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab dose-escalation trial in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantat

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21776

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21776

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34565132&oldid=1985074816"